Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surface Complex V couples proton gradient across the plasma membrane to ATP production in cancer.

Research square·2026
Same author

Surface Complex V couples proton gradient across the plasma membrane to ATP production in cancer.

bioRxiv : the preprint server for biology·2026
Same author

In Reply to: "Response to intra-arterial chemotherapy in patients with adenoid cystic carcinoma of lacrimal gland".

The oncologist·2026
Same author

Whole exome sequencing of sequential, ipsilateral HPV-positive conjunctival, and lacrimal sac squamous cell carcinomas.

Orbit (Amsterdam, Netherlands)·2026
Same author

Vertical Tarsal Plate Buckling Following Conjunctival Mullerectomy: An Unusual Complication.

Ophthalmic plastic and reconstructive surgery·2026
Same author

BCOR Mutations Deregulate Cell Cycle and Hypoxic Adaptation Pathways in Retinoblastoma.

Molecular cancer research : MCR·2025

Related Experiment Video

Updated: May 28, 2025

Partial Optic Nerve Transection in Rats: A Model Established with a New Operative Approach to Assess Secondary Degeneration of Retinal Ganglion Cells
13:12

Partial Optic Nerve Transection in Rats: A Model Established with a New Operative Approach to Assess Secondary Degeneration of Retinal Ganglion Cells

Published on: October 15, 2017

11.2K

A Polytherapy Intervention in an Experimental Traumatic Optic Neuropathy Mouse Model.

David T Tse1, Hua Wang1, Wensi Tao2

  • 1Department of Ophthalmology, Dr. Nasser Ibrahim Al-Rashid Orbital Vision Research Center, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, U.S.A.

Ophthalmic Plastic and Reconstructive Surgery
|February 13, 2025
PubMed
Summary

A novel polytherapy treatment targeting mitochondrial, excitotoxicity, and inflammatory pathways successfully protected retinal ganglion cells after optic nerve trauma. This approach preserved cell density and function, offering hope for vision recovery.

More Related Videos

Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy
04:02

Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy

Published on: November 29, 2024

989
An Optic Nerve Crush Injury Murine Model to Study Retinal Ganglion Cell Survival
09:07

An Optic Nerve Crush Injury Murine Model to Study Retinal Ganglion Cell Survival

Published on: April 25, 2011

30.5K

Related Experiment Videos

Last Updated: May 28, 2025

Partial Optic Nerve Transection in Rats: A Model Established with a New Operative Approach to Assess Secondary Degeneration of Retinal Ganglion Cells
13:12

Partial Optic Nerve Transection in Rats: A Model Established with a New Operative Approach to Assess Secondary Degeneration of Retinal Ganglion Cells

Published on: October 15, 2017

11.2K
Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy
04:02

Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy

Published on: November 29, 2024

989
An Optic Nerve Crush Injury Murine Model to Study Retinal Ganglion Cell Survival
09:07

An Optic Nerve Crush Injury Murine Model to Study Retinal Ganglion Cell Survival

Published on: April 25, 2011

30.5K

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Pharmacology

Background:

  • Optic nerve trauma leads to progressive retinal ganglion cell (RGC) loss.
  • Current treatments lack efficacy in halting RGC degeneration post-injury.
  • Understanding the molecular pathways involved is crucial for developing effective interventions.

Purpose of the Study:

  • To evaluate a novel polytherapy strategy for RGC survival after optic nerve trauma.
  • The strategy targets mitochondrial bioenergetics, glutamate excitotoxicity, and sterile inflammation.
  • Investigate the impact on structural and functional RGC integrity.

Main Methods:

  • Mice with sonication-induced traumatic optic neuropathy received a combination therapy including anti-inflammatory agents, NMDA receptor antagonists, and mitochondrial enhancers.
  • Treatment involved intravitreal, retrobulbar, and subcutaneous injections, plus oral N-acetylcysteine.
  • Functional (pattern electroretinogram) and structural (OCT, RGC counts) assessments were performed over 12 weeks.

Main Results:

  • The treatment group showed significantly higher RGC density and retinal layer thickness compared to the control group at 12 weeks.
  • Functional assessments revealed preserved electroretinogram amplitudes in the treatment group, unlike the control group.
  • Treated eyes showed no significant difference in RGC density or thickness compared to naive eyes.

Conclusions:

  • Early combinatorial therapy effectively halts progressive structural and functional degeneration of retinal neurons following optic nerve trauma.
  • The polytherapy approach addresses multiple molecular pathways critical for RGC survival.
  • This strategy holds promise for preserving vision after optic nerve injury.